Advanced Breast Cancer
09
Sep
A Randomized, Open-Label, Phase 3 Study of Fulvestrant and CDK4/6 Inhibitors With or Without Gedatolisib as First-Line Treatment in P...
Early Breast Cancer
23
Jul
Time and Motion Study of A Subcutaneous Fixed-Dose Combination Of Pertuzumab And Trastuzumab versus Intravenous Pertuzumab and Trastu...